Author:
Goodwin Daryn,Varamini Pegah,Simerska Pavla,Toth Istvan
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference51 articles.
1. Huggins C, Hodges CV. Studies on prostatic cancer—I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res. 1941;1(4):293–7.
2. Peptide Therapeutics Market—Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012–2018. Transparency Market Research; 2013.
3. Engel JB, Schally AV. Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Nat Clin Pract Endocrinol Metab. 2007;3(2):157–67.
4. Reichert J, Pechon P, Tartat A, Dunn MK. Development trends for peptide therapeutics: A comprehensive quantitative analysis of peptide therapeutics in clinical development. Peptide Therapeutics Foundation; 2010.
5. Brawer MK. The evolution of hormonal therapy for prostatic carcinoma. Rev Urol. 2001;3 Suppl 3:S1–9.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献